Altered expression of the CDH1 gene is known as a factor of epithelial to mesenchymal transition (EMT), where reduction of CDH1 is associated with increased motility and invasiveness of cancer cells and, hence, a worse prognosis. This evidence concerns the gene CDH1 and cancer.